Biocryst Pharmaceuticals (BCRX) Operating Leases (2020 - 2026)
Biocryst Pharmaceuticals (BCRX) recorded Operating Leases of $10.6 million in Q2 2026, up 24.9% from $8.49 million a year earlier but down 4.7% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Operating Leases (2020 - 2026) Analysis & Trends
At the end of FY2025, Biocryst Pharmaceuticals reported Operating Leases of $8.57 million, up 8.2% from FY2024.
- Annual Operating Leases has a five-year compound annual growth rate of 17.2% (FY2020 to FY2025).
- Across earlier years, Operating Leases came in at $7.92 million in FY2024 (-5.6%), $8.39 million in FY2023 (+108.3%), $4.03 million in FY2022 (-32.5%) and $5.96 million in FY2021 (+54.0%).
- Quarterly Operating Leases has ranged from $4.03 million in Q4 2022 to $11.12 million in Q1 2026 over the past five years.
- On a year-over-year basis, Operating Leases has increased for five consecutive quarters, with growth averaging 6.0% over the last eight quarters.
- Peak year-over-year performance for Operating Leases in the last five years was growth of 108.3% in Q4 2023, against a decline of 32.5% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $11.12 million (Q1 2026), $8.57 million (Q4 2025) and $8.43 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Biocryst Pharmaceuticals | 2.16 Bn | 1.08 Bn | 214.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.60 Mn |
| Mar 31, 2026 | 11.12 Mn |
| Dec 31, 2025 | 8.57 Mn |
| Sep 30, 2025 | 8.43 Mn |
| Jun 30, 2025 | 8.49 Mn |
| Mar 31, 2025 | 7.78 Mn |
| Dec 31, 2024 | 7.92 Mn |
| Sep 30, 2024 | 8.07 Mn |
| Jun 30, 2024 | 8.36 Mn |
| Mar 31, 2024 | 8.60 Mn |
| Dec 31, 2023 | 8.39 Mn |
| Sep 30, 2023 | 9.97 Mn |
| Jun 30, 2023 | 5.80 Mn |
| Mar 31, 2023 | 5.93 Mn |
| Dec 31, 2022 | 4.03 Mn |
| Sep 30, 2022 | 5.97 Mn |
| Jun 30, 2022 | 6.20 Mn |
| Mar 31, 2022 | 6.46 Mn |
| Dec 31, 2021 | 5.96 Mn |
| Dec 31, 2020 | 3.87 Mn |
API Access
Biocryst Pharmaceuticals Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();